As a type II transmembrane protein in basal keratinocytes, collagen XVII provides stable adhesion between epidermis and dermis in the skin. Its ectodomain can be shed from the cell surface, and autoantibodies in certain blistering diseases preferentially recognize the shed form. Major epitopes of collagen XVII are clustered within the juxtamembranous noncollagenous 16th A domain, and ectodomain shedding occurs within this region, suggesting that cleavage generates neoepitopes. However, the candidate cleavage sites have been controversial, and the mechanism of neoepitope generation is unclear. In this study, we investigated cleavage sites in the noncollagenous 16th A domain to understand the generation of neoepitopes and their pathological role. Polyclonal Abs recognizing the stretch Leu 524 -Gly 532 preferentially reacted with the shed ectodomain, but not with the full-length form, indicating that a neoepitope was localized at this site. The neoepitope-specific Ab fixed complement and induced granulocyte-dependent dermal-epidermal separation in cryosections of normal human skin. The physiological cleavage sites were identified using mass spectrometry. N termini were found at Asp 514 , Leu 524 , Glu 525 , and Gly 526 , among which Asp 514 and Glu 525 were blocked by acetylation and pyroglutaminate. In silico prediction of B cell epitopes indicated that the antigenicity of the Leu 524 -Gly 532 region increased substantially after shedding, regardless of the cleavage sites. Correspondingly, neoepitopes were found in the skin and blister fluids of patients with bullous pemphigoid, and bullous pemphigoid sera reacted with the peptide Leu 524 -Gly 532 . Taken together, these data demonstrate that physiological shedding of collagen XVII generates neoepitopes, which may serve as a target of blister-inducing autoantibodies. The Journal of Immunology, 2010, 185: 000-000. N early 2% of mammalian genes encode proteases, and processing of proteins is a crucial event (1) . Among different types of proteolysis, the release of extracellular domains of transmembrane proteins, mainly catalyzed by proteases of a disintegrin and metalloprotease (ADAM) family, is known as ectodomain shedding (2) . Ectodomain shedding is involved in functions of a variety of essential transmembrane proteins such as TNF-a, TGF-a, epidermal growth factor receptor ligands (2, 3) , or transmembrane collagens (4, 5) . All of type XIII, XVII, XXIII, and XXV collagens as well as ectodysplasin A are transmembrane proteins in type II orientation, with an intracytoplasmic N terminus and an extracellular C terminus, and their ectodomains can be shed. The shedding occurs within juxtamembranous noncollagenous domains, and is usually mediated by furin and/or ADAMs (4, 5) . However, the biological significance of these processes is still unclear.
Transmembrane collagen XVII, also known as BP180 or BPAG2, is widely expressed in skin (6) (7) (8) , cornea (7, 9) , teeth (10), buccal and esophageal mucous membranes (7), brain (11) , placenta, and umbilical cord (7) . Among these tissues, collagen XVII plays the most important role in the skin, where it is a component of hemidesmosomes in basal keratinocytes and provides stable adhesion between the epidermis and the dermis. Dysfunction of collagen XVII due to genetic or acquired diseases results in blistering phenotypes, as in junctional epidermolysis bullosa or bullous pemphigoid (BP), respectively (4, 8, 12) .
The ectodomain of collagen XVII is constitutively shed from the cell surface in vitro (4, 13, 14) . The shedding can be suppressed by a furin inhibitor, decanoyl-RVKR-chloromethyl keton, and there is actually a tribasic furin cleavage motif, -RIRR-, within the noncollagenous 16th A (NC16A) domain (13) . Although initial experiments suggested furin-mediated cleavage on collagen XVII, furin itself cannot cleave it in vitro (15) . Several lines of evidence, including inhibitor and overexpression studies, suggested that ectodomain shedding of collagen XVII is mediated by ADAMs (15) (16) (17) .
First, ADAM17 was thought to be the main sheddase for collagen XVII, but a recent study suggested that ADAM10 and 9 are mainly involved (18) . Thus, the mechanisms of shedding of collagen XVII, including the responsible sheddase(s), must still be elucidated in detail.
The question of the precise sheddase cleavage site in collagen XVII has been addressed by several investigations, which have yielded varying results. One study used protein extracted from normal human skin and suggested N-terminal cleavage at Ala 531 (19 in immortalized HaCat keratinocyte and DJM-1 cell lines (20) . In addition, structural modeling of ADAM17 with phosphorylated collagen XVII predicted Leu 540 to be a cleavage site (21) . In contrast, a further study showed that a mAb with an epitope within the amino acid stretch of Ser 515 to Arg 523 recognized the shed ectodomain of collagen XVII (22) , indicating that ectodomain shedding of collagen XVII could occur at different position(s), probably in a context-dependent manner.
Neoepitopes are newly appeared antigenic sites on cleaved protein fragments, which are not present in their uncleaved precursors (23) . Consequently, neoepitope-specific Abs have been used as a powerful tool to directly monitor cleavage events (1, 23) . Neoepitopes seem to be involved in human autoimmune diseases such as systemic lupus erythematosus (24) and especially in autoimmune blistering diseases of the pemphigoid group, including BP, pemphigoid gestationis, and linear IgA dermatosis (LAD). In BP and LAD, it is well known that IgG or IgA class autoantibodies preferentially react with the shed ectodomain of collagen XVII (25, 19, 26) . Furthermore, several Abs specifically targeting the shed ectodomain of collagen XVII have been reported in the literature (16, 19, 22, 26) . These findings indicate that shedding of collagen XVII generates neoepitopes within the shed ectodomain, which may play a role in the pathogenesis of autoimmune blistering diseases. However, it remains unclear whether ectodomain shedding of collagen XVII can actually generate neoepitopes that are involved in blister formation. To elucidate these questions, we generated what we believe are novel Abs that specifically target neoepitopes in the shed ectodomain of collagen XVII and tested their ability to induce dermal-epidermal separation in vitro. Furthermore, we used mass spectrometry (MS) to identify the cleavage sites in collagen XVII and could clearly disclose an association between ectodomain shedding and generation of neoepitopes.
Materials and Methods

Cell culture
Primary normal human keratinocytes (NHKs) were isolated from skin samples obtained from healthy volunteers after fully informed consent. NHKs were cultured in serum-free keratinocyte growth medium supplemented with bovine pituitary extract and epidermal growth factor (Invitrogen, Darmstadt, Germany). Cells up to the fourth passage were used for this study. Freshly prepared ascorbic acid was added into the culture medium (final concentration 50 mg/ml) every 48 h to allow hydroxylation of collagen and proper triple helix formation (13, 15) . Flp-in 293 host cells (Invitrogen) and transformed 293 cells were maintained in DMEM (Invitrogen) containing 10% FBS. The study was approved by the ethical committee of the University of Freiburg.
Production of Abs to candidate neoepitopes on the shed ectodomain of collagen XVII Based on previously described candidate cleavage sites on collagen XVII (19) (20) (21) , four different short peptides, 7-9 aa in length, and with nonblocked N termini, were prepared (Fig. 1A) . The peptides were coupled with keyhole limpet hemocyanin, and two New Zealand white rabbits per peptide were immunized (25) . Abs were affinity purified with the antigenic peptides coupled with AF-Amino TOYOPEARL (Tosho Bioscience, Stuttgart, Germany). Briefly, serum diluted with PBS was incubated with peptidebound beads, and after extensive washing, bound Abs were eluted with 0.1 M glycine (pH 2.5), followed by immediate neutralization with 1 M TrisHCl (pH 7.4). Purified Abs were dialyzed against PBS, and the concentration was measured by the bicinchoninic acid protein assay kit (Thermo Fisher Scientific, Schwerte, Germany). Affinity purification was also performed against N-terminally acetylated Leu 524 -Gly 532 peptide.
Generation of recombinant ectodomain of human collagen XVII
To generate a recombinant ectodomain of collagen XVII, corresponding to aa 490-1497, which can be secreted from stably expressing cells into the culture medium, PCR was first performed using primers His-ect-F, 59-GCAAGCTTGAGGAGGTGAGGAAGCTGAA-39 (underlined; HindIII), and His-ect R, 59-ATGCGGCCGCCGGCTTGACAGCAATACTTC-39 (underlined; NotI), using human collagen XVII cDNA as template (a gift of L. Borradori). After digestion with restriction enzymes, the PCR fragment was inserted into the HindIII to NotI sites of pSecTag2/HygroB vector (Invitrogen), designated as Ect-pSec. In addition, human COL17A1 cDNA was introduced into the NotI site of pcDNA5/FRT (Invitrogen), designated as COL17cDNA-pcDNA5. Next, the NheI-to ClaI-digested fragment from Ect-pSec was introduced into sites digested by the same enzymes of COL17cDNA-pcDNA5 to produce a vector with the Ig k-chain leader sequence and subsequent sequences encoding the collagen XVII ectodomain, designated as pSec-Ect-pcDNA5. Finally, a hexa-histidine fragment, in which an EcoRV site has been incorporated for further study, was introduced into the HindIII site of pSec-Ect-pcDNA5 using oligonucleotides 59-AGCTTCATCATCATCATCATCATGATATCA-39 and 59-AGCTTGATATCATGATGATGATGATGATGA-39 (underlined; EcoRV). As a result, the His-ect-pcDNA5 vector driven under CMV promoter, with the Ig k-chain leader sequence, hexa-histidine sequences, and collagen XVII ectodomain sequences spanning aa 490-1497, was produced. The same vector with a shorter fragment, D490-532 His-ect-pcDNA5, encoding the ectodomain with an N-terminal deletion of aa 490-532, was also generated using the EcoRV site by forward primer 59-GCGGATATCGCAGACC-TGGACAAAATTGG-39 (underlined; EcoRV) substitute for His-ect-F primer. Correct DNA sequences of all vectors were confirmed by direct sequencing. His-ect-pcDNA5, D490-532 His-ect-pcDNA5, COL17cDNA-pcDNA5, and the pcDNA5/FRT empty vector as control were cotransfected with pOG44 (Invitrogen) into Flp-In 293 host cells, and stably expressing cells were selected under 200 mg/ml hygromycin B (Invitrogen). The medium proteins, including His-ect, D490-532 His-ect, or that from control cells, were precipitated with ethanol, as described (15) .
Immunoblotting, immunostaining, and ELISA
For immunoblotting, subconfluent NHKs or transformed 293 cells were lysed for 30 min on ice in a buffer containing 1% Nonidet P-40, 0.1 M NaCl, 25 mM Tris-HCl (pH 7.4), 10 mM EDTA, and 1 mM Pefabloc (13) . The samples were separated on SDS-PAGE on 7% polyacrylamide gels, followed by transfer onto nitrocellulose membrane. Abs including mouse mAb NC16A-1 and NC16A-3 directed to different portions on NC16A domain of collagen XVII (22) and rabbit polyclonal Abs described above were used. After incubation with a HRP-conjugated secondary Ab, signals were visualized by ECL-plus (GE Healthcare, München, Germany). For immunohistochemistry, skin specimens were mounted and snap frozen in OCT compound. The following samples were processed: normal human skin, 1 M NaCl-split skin, skin of a collagen XVII-deficient patient with junctional epidermolysis bullosa and mutations in the COL17A1 gene (NM_000494) (12) , and skin obtained from blistering lesions of BP patients. Cryosections (5 mm) were incubated with 1:10 diluted NC16A-1 or 10 mg/ ml rabbit polyclonal Abs for 1 h at room temperature and detected with Alexa488-conjugated anti-mouse or anti-rabbit IgG (Invitrogen). The complement-fixing ability was assessed, as previously described (27) . Briefly, rabbit Abs to neoepitopes on the shed ectodomain of collagen XVII, preimmune rabbit serum, and rabbit polyclonal Abs to NC16A domain (25) as positive control, designated as pAb-NC16A, were incubated with cryosections of human skin at 37˚C for 30 min, followed by washing with PBS. Then the sections were treated with fresh human serum, diluted 1:5, for 30 min at 37˚C. Complement deposition was detected with a mAb to human C3 (Acris Antibodies, Herford, Germany).
ELISA index values against the NC16A domain of human collagen XVII and the peptide Leu 524 -Gly 532 were measured using sera of BP patients (n = 23) and of healthy volunteers (n = 23) using BP180 ELISA kit (MBL, Nagoya, Japan). For the peptide ELISA, 96-well plates were coated with 20 mg/ml peptide, and the absorbance was measured at 450 nm by microtiter plate readers (Bio-Rad, Hercules, CA).
Dermal-epidermal separation assay
Dermal-epidermal separation assays were performed using Abs, as previously described (28) . The ability of Abs to activate human leukocytes and induce dermal-epidermal separation was assessed, as described previously (28) .
Isolation of physiologically shed ectodomain of collagen XVII
NHK culture medium was concentrated by Amicon Ultrafilter (150 kDa; Millipore, Bedford, MA), and the proteins were precipitated with 50% saturated ammonium sulfate. After dialysis against PBS containing 10 mM EDTA, the proteins were dissolved in Laemmli sample buffer and separated on SDS-PAGE with 7% acrylamide gel under nonreducing conditions and without boiling. As the native trimerized form of collagen XVII ectodomain migrates at ∼360 kDa, gel bands approximately this size were excised, and the proteins were electroeluted from the gel using Dyalyzer electroelution chamber (Harvard Apparatus, Holliston, MA), according to the manufacturer's instructions. The eluted proteins were precipitated with 100% ethanol, then boiled and separated again by SDS-PAGE under denaturing conditions. A Coomassie blue-stained 120-kDa band corresponding to the monomer form of the ectodomain was cut from the gel and subjected to MS analysis.
For determination of the sheddase cleavage site in collagen XVII ectodomain, all free N termini, including those of the shedding products, were acetylated. Briefly, the electroeluted protein sample was boiled for 20 min, and the proteins were precipitated with 10% TCA for 30 min on ice. The precipitate was dissolved in PBS and treated with 40 mM sulfo-acetate normal human serum (Thermo Fisher Scientific), according to the manufacturer's instructions. The acetylated protein sample was directly loaded on SDS-PAGE, and Coomassie blue-stained 120-to 130-kDa bands corresponding to acetylated monomeric forms of the shed ectodomain were subjected for MS analysis.
Definition of the N terminus of the shed ectodomain by MS
Cut gel bands were subjected to in-gel digestion for MS. The bands were destained with 30% acetonitrile, shrunk with 100% acetonitrile, and dried in a vacuum concentrator (Concentrator 5301; Eppendorf, Wesseling-Berzdorf, Germany). In-gel digestion was performed with trypsin (Promega, Madison, WI), chymotrypsin (Roche, Basel, Switzerland), and elastase (MP Biomedicals, Solon, OH), in 0.05 M NH 4 HCO 3 (pH 8) overnight at 37˚C and with thermolysin (R&D Systems, Minneapolis, MN) for 2 h at 60˚C. Approximately 0.1 mg protease was used for one gel band. Peptides were extracted from the gel slices with 5% formic acid.
Liquid chromatography tandem MS (LC-MS/MS) analyses were performed on a 6520 Q-TOF and a 6340 ion trap equipped with an electron transfer dissociation (ETD) II source (Agilent Technologies, Palo Alto, CA). Both mass spectrometers were coupled to a 1200 Agilent nanoflow system via a HPLCChip cube electrospray ionization interface. Peptides were separated on a HPLC-Chip with an analytical column of 75 mm inner diameter and 150 mm length and a 40-nl trap column, both packed with Zorbax 300SB C-18 (5 mm particle size). Peptides were eluted with a linear acetonitrile gradient with 1%/ min at a flow rate of 300 nl/min (starting with 3% acetonitrile). The Q-TOF was operated in the 2 Ghz extended dynamic range mode. MS/MS analyses were performed using data-dependent acquisition mode. After a MS scan (2 spectra/ s), a maximum of three peptides was selected for MS/MS (2 spectra/s). Singly charged precursor ions were excluded from selection. Internal calibration was applied using two reference masses. ETD analyses on the ion trap were performed using data-dependent acquisition mode. After a MS scan (standard enhanced mode), a maximum of three peptides was selected for ETD-MS/MS (standard enhanced mode). The automated gain control (ion charge control) for MS scans was set to 350,000. The maximum accumulation time was set to 300 ms. The following ETD parameters were used: ion charge control target, 400,000; reaction time, 100 ms; cutoff, 140; resonance excitation (smart decomposition) was used for doubly charged peptides. Mascot Distiller 2.1 was used for raw data processing and for generating peak lists, essentially with FIGURE 1. A schematic representation of collagen XVII and characterization of Abs targeting neoepitopes. A, Collagen XVII is a type II integral transmembrane protein, with an intracellular N terminus and an extracellular C terminus. The ectodomain can be shed from cell surface through cleavage within the NC16A domain. Below the scheme, the amino acid sequence of the NC16A domain, spanning aa 490-566, is delineated. A furin recognition motif, -RIRRS-, is shown in the box. The black bars indicate the peptides used to generate different Abs to target candidate cleavage sites indicated with red arrowheads. The gray bars show the epitopes of mAbs produced previously (22) . B, Abs 83457 and 83458 preferentially reacted with the shed ectodomain of collagen XVII (arrows), whereas Ab 83460 equally bound to both shed and full-length forms (arrowheads) on immunoblotting. Reactivity of Ab 83459 to shed ectodomain of collagen XVII was very faint (data not shown). C, mAb NC16A-1 reacted only to recombinant His-ect protein, whereas mAb NC16A-3 recognized both His-ect and D490-532 His-ect proteins. Ab 83457 only reacted to recombinant His-ect and lost the reactivity to D490-532 His-ect proteins lacking epitope for Ab 83457, suggesting specificity of this Ab to the epitope. D, Distinctive staining patterns of the neoepitope-specific Ab 83457 and the mAb NC16A-1. Ab 83457 stained the dermal-epidermal junction in a linear fashion, whereas mAb NC16A-1 showed intensive basolateral cytoplasmic staining, with only slight linear signals along the dermal-epidermal junction. E, Ab 83457 stained the epidermal side of salt-split skin. Star: salt-induced artificial blister. F, Ab 83457 did not stain collagen XVII-deficient skin of a patient with junctional epidermolysis bullosa. The arrows indicate the position of the dermal-epidermal junction. Star: spontaneous blister. Scale bar, 40 mm Original magnification 3400. TM, transmembrane. standard settings for the Agilent Q-TOF and the Agilent ion trap. Mascot Server 2.2 was used for database searching using a small custom database containing the protein sequence of collagen XVII. All relevant MS/MS spectra were validated manually.
Prediction of B cell epitopes on shed ectodomain of collagen XVII
Based on the disclosed cleavage sites, continuous B cell epitopes on cleaved fragments and the entire NC16A domain (spanning aa 490-566) were predicted, and the antigenic propensity scores were calculated by COBEpro software (29) .
In vitro digestion of recombinant collagen XVII by blister fluid from BP patients Collagen XVII-expressing Flp-in 293 cells transfected with COL17cDNA-pcDNA5 were treated with 0.1 mM furin inhibitor I (Calbiochem, San Diego, CA) overnight, and cell lysates were coupled with a cation exchange column (Vivapure S; Sartorius Stedim, Edgewood, NY). Full-length collagen XVII was eluted with a gradient of 0.4-1.0 M NaCl, followed by dialysis against PBS. A total of 10 ml collagen XVII was incubated with 1 ml blister fluid obtained from three BP patients for 1 h at 37˚C. To discern the responsible proteases, protease inhibitors including 10 mM EDTA, 1-5 mM Pefabloc, 3-50 mM Marimastat (British Biotechnology, Oxford, U.K.), 10 mg/ml chymostatin (Calbiochem), 70 mg/ml a2-antiplasmin (Calbiochem), and 100 mg/ml soybean trypsin inhibitor (Calbiochem) were added to the enzyme reaction.
Purification of Ab 83457
Purified recombinant full-length collagen XVII was coupled with NSHactivated Sepharose (GE Healthcare) and used to immunoadsorb Ab 83457 to eliminate minimal reactivity with the full-length form of collagen XVII.
Immunoprecipitation of ectodomain of collagen XVII from blister fluid of BP patients
The ectodomain of collagen XVII was immunoprecipitated from blister fluid of BP patients with Ab 83457 and normal rabbit IgG as a control (22) . Briefly, 100 ml blister fluid was dialyzed against PBS and precleared with 100 ml protein G Dynabeads (Invitrogen). After extensive washing, the sample was incubated with 10 mg Ab 83457 or normal rabbit IgG overnight at 4˚C, and then reacted with 100 ml protein G Dynabeads for 1 h at room temperature. The samples were eluted with SDS sample buffer and separated by SDS-PAGE, and the ectodomain of collagen XVII was detected by immunoblotting using mAb NC16A-3.
Results
Abs target neoepitopes in the shed ectodomain of collagen XVII
In this study, we used 7-to 9-aa-long peptides to generate Abs, which recognize shedding-associated epitopes in collagen XVII (Fig. 1A) . Three of four different Abs to target candidate cleavage sites worked well (Fig. 1B) . Abs 83457 and 83458 preferentially reacted with the shed ectodomain, whereas Ab 83460 bound equally well to both the shed and the full-length forms in cell lysates of NHKs (Fig. 1B) . The reactivity of Ab 83459 was very faint, and this Ab was not used. These findings suggest that Abs 83457 and 83458 target neoepitopes in the shed ectodomain of collagen XVII. The specific reactivity of Ab 83457 with the shed ectodomain of collagen XVII did not change when N-terminally acetylated Leu 524 -Gly 532 peptide was used for affinity purification of the Ab (data not shown). Ab 83457 reacted with the recombinant FIGURE 2. Neoepitope-specific Ab 83457 against human collagen XVII ectodomain fixes complement and induces dermal-epidermal separation on human skin cryosections. IgG from rabbits immunized against the entire NC16A domain (pAb-NC16A), Ab 83457, and preimmune rabbit serum was incubated with human skin cryosections. IgG from pAb-NC16A (a) and Ab 83457 (b), but not preimmune serum (c) bound to the dermal-epidermal junction. When fresh human serum as source of complement was added, both pAb-NC16A (d) and Ab 83457 (e) fixed complement C3 at the dermal-epidermal junction. In contrast, preimmune serum (f) did not fix complement. Subsequent addition of normal human leukocytes resulted in dermal-epidermal separation in sections treated with IgG from pAb-NC16A (g) and Ab 83457 (h), but not from preimmune serum (i). Original magnification 3400.
full-length His-ect, but not with the D490-532 His-ect deletion mutant (Fig. 1C) , verifying the specificity of this Ab and reactivity with a collagen XVII epitope. Correct expression of His-ect and D490-532 His-ect was also confirmed with the reactivity of mAb NC16A-1 and NC16A-3 (Fig. 1C) .
Of the newly generated Abs, only Ab 83457 recognized native collagen XVII in normal human skin in immunofluorescence staining; it produced linear signals at the dermal-epidermal junction. In comparison, the mAb NC16A-1, which recognizes an epitope in close vicinity, showed intensive basolateral cytoplasmic staining in addition to a slight linear signal along the dermalepidermal junction (Fig. 1D) . Although collagen XVII is a transmembrane protein, substantial expression can be observed in the cytoplasm of basal keratinocytes (14, 16) . Thus, the specific linear staining pattern of Ab 83457 indicates that collagen XVII present in the cytoplasm does not contain neoepitopes, and that the shed ectodomain is actually present along the dermal-epidermal junction, as a consequence of proteolytic cleavage on the basal cell surface. The specificity of Ab 83457 was corroborated by the fact that it stained the epidermal side on salt-split skin (Fig. 1E) and remained negative on collagen XVII-deficient skin of a patient with junctional epidermolysis bullosa and the mutations 1392G. A/p.W464X in the COL17A1 gene (Fig. 1F) .
Collagen XVII neoepitope-specific Ab fixed complement and induced dermal-epidermal separation in cryosections of human skin A major diagnostic and pathogenic feature of pemphigoid IgG autoantibodies is their capacity to activate the complement system (27, 28) . To assess the capacity of rabbit IgG Abs recognizing different forms of collagen XVII to bind complement, an in vitro complement-fixation assay was performed using pAb-NC16A and Ab 83457. Both Abs bound to the dermal-epidermal junction of normal human skin and showed complement-fixing activity (Fig.  2a, 2b, 2d, 2e) . In contrast, the IgG fraction from a preimmune rabbit did not stain the dermal-epidermal junction nor show complement-binding capacity (Fig. 2c, 2f) .
Several lines of evidence indicate that recruitment and activation of granulocytes by autoantibodies after binding to the dermalepidermal junction are a prerequisite for blister formation in pemphigoid diseases (27, 28) . Therefore, to characterize the granulocyteactivating ability of the collagen XVII neoepitope-specific Ab, we used an ex vivo Ab-induced granulocyte-dependent assay having as readout dermal-epidermal splits in cryosections of normal human skin (27, 28) . Incubation of cryosections with the pAb-NC16A (Fig.  2g) and Ab 83457 (Fig. 2h ), but not with the control IgG (Fig. 2i) , resulted in subepidermal cleavage when coincubated with leukocytes from healthy donors.
MS revealed different shedding sites within the NC16A domain of collagen XVII
The fact that collagens spontaneously fold into a triple helix allowed us to obtain a highly purified shed ectodomain of collagen XVII for MS analysis. On SDS-PAGE, the triple-helical shed ectodomain migrated at ∼360 kDa (13, 14) , and the excision of this band eliminated contaminating proteins smaller than 300-330 kDa. The band was subjected to a second SDS-PAGE under denaturing conditions, which presented the distinct unfolded 120-kDa monomer (Fig. 3A, 3B ). The efficiency of this procedure was very high, and 40 ml culture medium was sufficient to generate the 120-kDa Coomassie blue-stained band seen in Fig. 3B .
Multiple LC-MS/MS analyses with different proteases detected several candidates for N-terminal peptides of the shed ectodomain (Table I) . Among them, two peptides with a free N-terminal amino group starting with Leu 524 and Gly 526 were highly likely to be physiological cleavage sites. For differentiation between true N-terminal peptides (generated by a protease in vivo) and peptides generated by a protease during in-gel digestion, the samples were acetylated before second SDS-PAGE. This enabled us to block all free N termini, including unblocked cleavage sites. As a result, FIGURE 3 . Proteomics strategy for determination of sheddase cleavage sites in collagen XVII using LC-MS/MS. The physiologically shed ectodomain of collagen XVII in NHK culture medium was concentrated and subjected to SDS-PAGE under nondenaturing conditions. The trimeric ectodomain migrates at ∼360 kDa. Therefore, the gel bands in this migration position were excised, and the proteins were electroeluted for further analysis. A, Immunoblotting of electroeluted samples. Under nondenaturing conditions (without boiling), the trimeric forms of the shed ectodomain of collagen XVII only penetrate into the upper gel. In contrast, under denaturing conditions (after boiling), a distinct 120-kDa band corresponding to the monomeric form of shed ectodomain is seen. B, The Coomassie blue-stained 120-kDa band, corresponding to the monomeric form of the shed ectodomain under denaturing conditions, was cut and subjected to MS analysis. C, In the schematic representation of collagen XVII, the cleavage sites identified by MS are indicated with arrows within the NC16A sequence. Notably, the cleavage sites were not associated with the furin consensus motif (box), and the cleavage sites, Leu (Table I) , indicating these N termini are cleavage sites without modifications (Fig. 3C) .
Interestingly, the N terminus of a peptide starting at Asp 514 was naturally blocked by acetylation. This novel, to our knowledge, cleavage site clarified why mAb NC16A-1, with epitopes located N-terminally of Leu 524 (Fig. 1A) , had been shown to react with the shed ectodomain of collagen XVII (22) . Several attempts to define the N termini of the shed ectodomain by Edman degradation have failed in the past. The present experiments explained this by demonstrating that the N terminus of the fragment starting at Asp 514 was blocked by acetylation and the N terminus of the peptide starting at Gln 525 was also blocked by pyroglutamate. The fragment starting at Gln 525 was detected by trypsin and thermolysin digestion. Trypsin digestion showed low chymotrypsin-like activity (data not shown); therefore, it was not possible to exclude the possibility for Gln 525 to be an artificial terminus. However, thermolysin digestion also could detect this fragment, and elastase has been reported to cut after Leu with ∼20% probability (30), suggesting that Gln 525 is a true cleavage site. FIGURE 4. Prediction of B cell epitopes on NC16A domain of collagen XVII before and after ectodomain shedding. Net votes for epitopes around Leu 524 to Gly 532 of the Ab 83457 were totally negative on long sequences covering entire NC16A domain. In contrast, distinctive epitopes appeared in this region when shedding of the ectodomain was included in the prediction. The appearance of the novel (to our knowledge) epitopes did not depend on one particular cleavage site.
In silico prediction of neoepitopes in each of the shed ectodomains
Detection of four different, distinct N termini on shed ectodomains of collagen XVII eliminated the previous discrepancies regarding N termini and immunoreactivity of several Abs. In addition, the preferential reactivity of Ab 83457 with the shed ectodomain of collagen XVII proved that distinct neoepitopes were generated by the shedding. The next question was how neoepitopes developed after shedding of collagen XVII. To address this, we used the COBEpro software (29) to predict continuous B cell epitopes within the NC16A domain of collagen XVII. This showed that predicted antigenic propensity scores were very low in the middle and Cterminal portions of the intact NC16A domain, spanning amino acids Leu , suggesting that these stretches refold upon shedding and become highly antigenic. These neoepitopes are recognized by the mAb NC16A-1 and Ab 83457, respectively (Fig. 4) .
BP blister fluid generates 120-kDa ectodomain of collagen XVII in vitro
To assess the possibility that BP blister fluids can hydrolyze collagen XVII, in vitro digestions were performed. Incubation of recombinant collagen XVII with blister fluid of three BP patients (BP13, BP29, and BP87) yielded a stable 120-kDa ectodomain detectable with the mAb NC16A-3 and Ab 83457 (Fig. 5A) . Control blister fluids obtained from suction blisters in healthy volunteers also generated minor amounts of the 120-kDa ectodomain (Fig. 5A) , consistent with our previous report showing that blister fluids contain proteolytic enzymes (22) .
For further characterization of the enzymes hydrolyzing collagen XVII, different protein inhibitors were employed. Among them, 5 mM Pefabloc inhibited the digestion moderately (Fig. 5B) . Because Pefabloc is a broad serine protease inhibitor, chymostatin, a2-antiplasmin, and soybean trypsin inhibitor were also tested. As a result, a2-antiplasmin and soybean trypsin inhibitor moderately inhibited the hydrolysis (Fig. 5B) , implicating involvement of plasmin and trypsin-like enzymes in the digestion of collagen XVII. Although mAb NC16A-3 reacted intensively with the hydrolyzed 120-kDa ectodomain of collagen XVII, the neoepitopespecific Ab 83457 did not considerably change its reactivity between physiological (without blister fluid) and pathological (with blister fluid) setting (Fig. 5A, 5B ). This suggests that the cleavage by different proteases in the blister fluid may occur at different sites, although further details remain to be elucidated.
Collagen XVII neoepitopes in BP
The above data suggested the involvement of collagen XVII neoepitopes in the pathogenesis of BP. The next question was whether autoantibodies in BP patients actually react with the neoepitopes and whether ectodomains containing neoepitopes exist in tissues. ELISAs demonstrated that a number of BP sera reacted with the peptide Leu 524 -Gly 532 , indicating that the neoepitope is recognized by circulating Abs in BP patients (Fig. 6A) . Furthermore, the neoepitope-specific Ab 83457 immunoprecipitated the ectodomain from blister fluids of two BP patients (Fig. 6B ). These observations delivered evidence for in vivo emergence of neoepitopes within the ectodomain of collagen XVII and presence of autoantibodies to these neoepitopes in at least some patients with BP.
Adsorption of the Ab 83457 with recombinant full-length collagen XVII abrogated its minor reactivity with the full-length form (Fig. 7A) . In immunofluorescence staining, the purified Ab specifically reacted with perilesional, still nonblistering skin areas in all three BP patients (Fig. 7B) , indicating involvement in early lesions. In addition, intracytoplasmic staining was observed in two patients, and a mottled staining was seen along the dermalepidermal junction in one patient, possibly corresponding to the released ectodomain of collagen XVII (Fig. 7B) . Control IgG failed to yield any signals (data not shown).
Discussion
In this study, we disclosed distinctive neoepitopes and what we believe are novel cleavage sites on the NC16A domain of collagen XVII. In silico prediction of B cell epitopes indicated that neoepitopes were evoked by ectodomain shedding, and in vitro tests demonstrated that the neoepitope-specific Ab could induce blister formation in human skin. Furthermore, the presence of neoepitopes was demonstrated in BP patients. On one hand, circulating autoantibodies in BP sera recognized the neoepitope-containing peptide Leu 524 -Gly 532 in ELISAs. On the other hand, the neoepitopecontaining ectodomain of collagen XVII was present in blister fluids of BP patients. Blister fluids contained proteases that hydrolyzed full-length collagen XVII into the 120-kDa ectodomain in vitro. Finally, a distinctive expression pattern of neoepitopes was disclosed in lesional skin of BP patients. These results suggest FIGURE 5 . Proteases in blister fluid of BP patients generate the 120-kDa ectodomain of collagen XVII in vitro. A, Incubation of blister fluid from three BP patients (BP13, BP29, and BP87) with recombinant full-length collagen XVII generated the stable 120-kDa ectodomain of collagen XVII (arrows). Note that blister fluid from an artificial suction blister from a healthy volunteer also generated small amounts of the 120-kDa ectodomain. B, Pefabloc moderately inhibited the cleavage of the ectodomain of collagen XVII by BP blister fluid (one representative set of data using 5 mM Pefabloc and blister fluid from patient BP29). The cleavage was moderately suppressed by a2-antiplasmin and soybean trypsin inhibitor. Note that mAb NC16A-3 reacted intensively with the hydrolyzed 120-kDa ectodomain of collagen XVII, whereas Ab 83457 did not significantly change its reactivity between physiological (without blister fluid) and pathological (with blister fluid) settings. a strong association between ectodomain shedding and evolution of neoepitopes on the NC16A domain of collagen XVII.
The neoepitope Leu
524
-Gly 532 on the NC16A domain lies adjacent to one of the cleavage sites and includes the N terminus at Leu 524 (20) . Neoepitope-specific Abs usually target positively charged free N termini generated by protease digestion (23) . In concert, Ab 83457, which was produced by immunization against the peptide Leu . Ectodomain shedding of collagen XVII is catalyzed by ADAM proteases, especially by ADAM17 (15, 17, 21) , 9, and 10 (15, 18). ADAMs do not require a specific cleavage consensus sequence, but cleave their transmembrane substrates at a defined length from the cell surface (17, 31) . Thus, it is highly likely that the main collagen XVII cleavage sites lie within the region Leu 524 -Gly
526
. The fact that immunoreactivity of Ab 83457 did not significantly change upon affinity purification with an N-terminally acetylated peptide may point to Gln 525 as the major N-terminal cleavage site, which has been blocked by pyroglutaminate. This would explain why Ab 83457 could also react with the blocked neoepitopes.
It has been a mystery why autoantibodies in autoimmune blistering diseases of the pemphigoid group, especially in LAD, preferentially react with the shed ectodomain of collagen XVII and less with its full-length form (32, 33) . Previous investigations have yielded variable results and interpretations. One study showed that autoantibodies in a subgroup of patients with LAD specifically reacted with NC16A domain of collagen XVII (34) , which is consistent with the current study. In contrast, in another group of LAD patients, IgA autoantibodies were shown to react selectively with 15th collagenous domain (32) , suggesting that development of neoepitopes on collagen XVII could occur in more extended regions. This is supported, for example, by the fact that the mAb NC16A-3, which recognizes the sequence Gln 545 -Met 557 , preferentially reacted with the shed ectodomain of collagen XVII on immunoblotting (22) . However, the full scenario of neoepitope 1-4, 10-1 .25 mg/ml) before and after immunoadsorption. B, Indirect immunofluorescence staining of the skin of three BP patients with 5 mg/ml affinity-purified Ab 83457 (designated as Ab HK139). Different from expression pattern detected by a polyclonal Ab to NC16A, Ab HK139 specifically reacted with the nonblistering areas in the periphery of the lesions in all three BP patients. In addition, the Ab showed intracytoplasmic staining in two patients (BP 09-115 and 09-275), and a mottled staining along the dermal-epidermal junction in one patient (BP 09-115, arrowheads), which may reflect the released ectodomain of collagen XVII. Stars: blister. Scale bar, 160 mm. Original magnification 3100. development still remains elusive at least in part. Possible changes in folding of the collagenous triple helix structures within the ectodomain must be considered (15) . Although the neighbor of the NC16A domain, the 15th collagenous domain, is quite stable and can form a triple-helical structure by itself when expressed as a recombinant fragment (35, 36) , it is still possible that conformational or other changes take place after shedding of the entire ectodomain. This assumption is in line with observations that IgA from LAD serum can also react with full-length collagen XVII, if the incubation temperature is increased (37), because it is well known that collagen triple helices unfold in higher temperatures.
Autoantibodies from patients with BP or epidermolysis bullosa acquisita show complement-and leukocyte-activating capacity, which appear to be main determinants of their pathogenicity (28, 38) . Therefore, we assessed these two major pathogenic features of the neoepitope-specific Ab 83457. Complement activation was measured by an immunofluorescence microscopy test assessing the classical pathway. The granulocyte-activating capacity of the Ab was evaluated by an ex vivo model of Ab-induced granulocytedependent dermal-epidermal separation in cryosections of human skin incubated with the Ab in the presence of leukocytes. These experiments demonstrated that, in analogy to human autoantibodies in BP, the neoepitope-specific Ab 83457 can fix human complement and induce granulocyte activation ex vivo.
Another commonly used method to verify the pathogenicity of autoantibodies is the passive transfer of IgG from patients into mice to test blister induction (39, 40) . In the case of BP, this has not succeeded yet, because the amino acid sequences of the epitope region within the NC16A domain differ significantly between humans and animals (39) . To overcome the species' differences, a collagen XVII-humanized mouse has been developed to reproduce the BP phenotype (40, 41) , but ectodomain shedding of human collagen XVII in the mouse skin has not yet been precisely analyzed. Therefore, currently, the in vitro dermal-epidermal separation assay is most suitable to verify the ability of the Abs to induce blister formation.
In this study, a novel (to our knowledge) and simple approach allowed determination of the N termini of shed ectodomain of collagen XVII. Previously, low amounts of the shed ectodomain in the skin or in primary cell cultures, tedious protein isolation protocols, and blocked N termini have hampered corresponding efforts (20, 22) . Although MS protocols for determining the N termini of abundant proteins are well established (42, 43) , this has not been the case for proteins present at low concentrations. To solve this problem, we took advantage of the collagenous nature of the shed ectodomain of collagen XVII that forms a relatively stable trimer (14) and used successive SDS-PAGE runs, which increased the target protein while decreasing background proteins. The high molecular mass trimerized ectodomain was isolated first and then subjected to a second SDS-PAGE under denaturing conditions, which enabled isolation of sufficient amounts of highly purified shed ectodomain for MS analysis. Furthermore, acetylation of the ectodomain labeled free N termini, which could then be defined as cleavage sites by MS. Acetylation of free N termini is a very useful method (42, 43) to distinguish in vitro processed fragments from those digested during in-gel fragmentation for MS. The simple and powerful method described in this work can be easily used to find shedding-generated, to our knowledge, novel N termini in other type II transmembrane collagens and other proteins forming tight complexes.
Digestion of recombinant full-length collagen XVII with blister fluids from BP patients produced the 120-kDa ectodomain, which could be moderately inhibited by a2-antiplasmin and soybean trypsin inhibitor. Plasmin has been suggested to play a role in early blistering skin lesions of BP (44) and in the generation of the LAD autoantigen, which is also a digestion product of ectodomain of collagen XVII (22) . Thus, based on the above arguments, the 120-kDa neoepitope-containing ectodomain seems to be involved in the pathogenesis of BP. However, in vivo expression of the neoepitopes in lesional BP skin has remained unknown. In this study, we used affinity-purified Ab83457, which has no reactivity with full-length collagen XVII, to demonstrate a distinctive expression pattern of the neoepitopes in the periphery of blisters, in nonblistering areas, indicating association with early BP lesions. The reactivity was not seen in overt blistering, probably due to loss of epitopes through nonspecific tissue proteolysis in inflamed skin. Another possibility is that the neoepitope-containing ectodomain diffuses into the blister fluid. This is supported by the observation that Ab 83457 immunoprecipitated the ectodomain from BP blister fluids. In some instances, Ab 83457 revealed intracytoplasmic staining in nonblistering skin. Internalization of collagen XVII has been suggested in BP (45), which may be a possible mechanism for this particular finding.
Taken together, we deliver clear evidence for shedding-generated neoepitopes on the NC16A domain of collagen XVII, which are highly likely to be involved in the pathogenesis of autoimmune blistering skin diseases, such as BP or LAD.
